InsiderTrades

Form 4 for TNDM TANDEM DIABETES CARE INC

Accepted 2026-07-17 16:07:23 ET · period of report 2026-07-15 · accession 0001438133-26-000116 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-07-17 16:07 2026-07-15 TNDM Kyrillos Jean-Claude EVP, COO M - OptEx $0.00 +3,636 31.7K +13% $0
D 2026-07-17 16:07 2026-07-15 TNDM Kyrillos Jean-Claude EVP, COO F - Tax $15.28 -1,926 29.8K -6% -$29.4K
D 2026-07-17 16:07 2026-07-15 TNDM Kyrillos Jean-Claude EVP, COO M - OptEx $0.00 -3,636 14.5K -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-07-15 M A 3,636 $0.00 31,741 D — —
2 Common Common Stock 2026-07-15 F D 1,926 $15.28 29,815 D — — (F1) Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold.
3 Derivative Restricted Stock Unit 2026-07-15 M D 3,636 $0.00 14,545 D — · — to — 3,636 Common Stock (F2) Awarded on July 15, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). (F3) Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. (F4) One-third of the RSUs granted on July 14, 2024 vested on July 14, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan. (F4) One-third of the RSUs granted on July 14, 2024 vested on July 14, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.